• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环中的无活性基质Gla蛋白(ucMGP)作为心血管钙化的生物标志物。

The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification.

作者信息

Cranenburg Ellen C M, Vermeer Cees, Koos Ralf, Boumans Marie-Louise, Hackeng Tilman M, Bouwman Freek G, Kwaijtaal Martijn, Brandenburg Vincent M, Ketteler Markus, Schurgers Leon J

机构信息

VitaK, Maastricht University, Maastricht, The Netherlands.

出版信息

J Vasc Res. 2008;45(5):427-36. doi: 10.1159/000124863. Epub 2008 Apr 10.

DOI:10.1159/000124863
PMID:18401181
Abstract

OBJECTIVE

Matrix gamma-carboxyglutamate (Gla) protein (MGP) is a vitamin K-dependent protein and a strong inhibitor of vascular calcification. Vitamin K deficiency leads to inactive uncarboxylated MGP (ucMGP), which accumulates at sites of arterial calcification. We hypothesized that as a result of ucMGP deposition around arterial calcification, the circulating fraction of ucMGP is decreased. Here we report on the development of an ucMGP assay and the potential diagnostic utility of monitoring serum ucMGP levels.

METHODS AND RESULTS

An ELISA-based assay was developed with which circulating ucMGP can be determined. Serum ucMGP levels were measured in healthy subjects (n = 165) and in four patient populations; patients who underwent angioplasty (n = 30), patients with aortic stenosis (n = 25), hemodialysis patients (n = 52), and calciphylaxis patients (n = 10). All four patient populations had significantly lower ucMGP levels. In angioplasty patients and in those with aortic stenosis, some overlap was observed with the control population. However, in the hemodialysis and calciphylaxis populations, virtually all subjects had ucMGP levels below the normal adult range.

CONCLUSION

Serum ucMGP may be used as a biomarker to identify those at risk for developing vascular calcification. This assay may become an important tool in the diagnosis of cardiovascular calcification.

摘要

目的

基质γ-羧基谷氨酸(Gla)蛋白(MGP)是一种维生素K依赖蛋白,也是血管钙化的强效抑制剂。维生素K缺乏会导致无活性的未羧化MGP(ucMGP),其在动脉钙化部位蓄积。我们推测,由于ucMGP在动脉钙化周围沉积,其循环部分会减少。在此,我们报告ucMGP检测方法的开发以及监测血清ucMGP水平的潜在诊断效用。

方法与结果

开发了一种基于酶联免疫吸附测定(ELISA)的方法,可用于测定循环中的ucMGP。对健康受试者(n = 165)和四类患者群体的血清ucMGP水平进行了测量;接受血管成形术的患者(n = 30)、主动脉瓣狭窄患者(n = 25)、血液透析患者(n =  52)和钙化防御患者(n = 10)。所有四类患者群体的ucMGP水平均显著降低。在血管成形术患者和主动脉瓣狭窄患者中,观察到与对照组有一定重叠。然而,在血液透析和钙化防御人群中,几乎所有受试者的ucMGP水平均低于正常成人范围。

结论

血清ucMGP可用作生物标志物,以识别有发生血管钙化风险的人群。该检测方法可能成为心血管钙化诊断的重要工具。

相似文献

1
The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification.循环中的无活性基质Gla蛋白(ucMGP)作为心血管钙化的生物标志物。
J Vasc Res. 2008;45(5):427-36. doi: 10.1159/000124863. Epub 2008 Apr 10.
2
Uncarboxylated matrix Gla protein (ucMGP) is associated with coronary artery calcification in haemodialysis patients.未羧化基质γ-羧基谷氨酸蛋白(ucMGP)与血液透析患者的冠状动脉钙化有关。
Thromb Haemost. 2009 Feb;101(2):359-66.
3
Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women.循环基质 Gla 蛋白与健康女性的冠状动脉钙化和维生素 K 状态相关。
J Nutr Biochem. 2013 Apr;24(4):624-8. doi: 10.1016/j.jnutbio.2012.02.012. Epub 2012 Jul 20.
4
Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification.新型抗基质γ-羧基谷氨酸(Gla)蛋白构象特异性抗体:未羧化基质Gla蛋白作为血管钙化的标志物
Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1629-33. doi: 10.1161/01.ATV.0000173313.46222.43. Epub 2005 Jun 16.
5
Calcium scores and matrix Gla protein levels: association with vitamin K status.钙评分和基质 Gla 蛋白水平:与维生素 K 状况的关联。
Eur J Clin Invest. 2010 Apr;40(4):344-9. doi: 10.1111/j.1365-2362.2010.02275.x.
6
Undercarboxylated matrix GLA protein levels are decreased in dialysis patients and related to parameters of calcium-phosphate metabolism and aortic augmentation index.羧化不全的基质GLA蛋白水平在透析患者中降低,且与钙磷代谢参数及主动脉增强指数相关。
Blood Purif. 2007;25(5-6):395-401. doi: 10.1159/000108629. Epub 2007 Sep 20.
7
Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species.循环基质 Gla 蛋白 (MGP) 种类的特征及其潜在的诊断价值。
Thromb Haemost. 2010 Oct;104(4):811-22. doi: 10.1160/TH09-11-0786. Epub 2010 Aug 5.
8
Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial.维生素 K2 补充对血液透析患者功能性维生素 K 缺乏的影响:一项随机试验。
Am J Kidney Dis. 2012 Feb;59(2):186-95. doi: 10.1053/j.ajkd.2011.10.041. Epub 2011 Dec 9.
9
Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease.循环中未羧化基质Gla蛋白,一种维生素K状态的标志物,作为心血管疾病的危险因素。
Maturitas. 2014 Feb;77(2):137-41. doi: 10.1016/j.maturitas.2013.10.008. Epub 2013 Oct 24.
10
Matrix Gla-protein: the calcification inhibitor in need of vitamin K.基质Gla蛋白:一种需要维生素K的钙化抑制剂。
Thromb Haemost. 2008 Oct;100(4):593-603.

引用本文的文献

1
Arterial stiffness and vascular aging: mechanisms, prevention, and therapy.动脉僵硬度与血管衰老:机制、预防及治疗
Signal Transduct Target Ther. 2025 Sep 1;10(1):282. doi: 10.1038/s41392-025-02346-0.
2
Vitamin K1 Administration Increases the Level of Circulating Carboxylated Osteocalcin in Critically Ill Patients.维生素K1给药可提高危重症患者循环中羧化骨钙素的水平。
Nutrients. 2025 Jan 19;17(2):348. doi: 10.3390/nu17020348.
3
Prevalence of Vitamin K2 Deficiency and Its Association with Coronary Artery Disease: A Case-Control Study.
维生素K2缺乏症的患病率及其与冠状动脉疾病的关联:一项病例对照研究。
Diseases. 2025 Jan 11;13(1):12. doi: 10.3390/diseases13010012.
4
Why Current Detection of Vascular Calcification Falls Short and How to Improve on It.当前血管钙化检测为何存在不足以及如何加以改进。
TH Open. 2024 Dec 27;8(4):e340-e349. doi: 10.1055/a-2495-1444. eCollection 2024 Oct.
5
Converging Mechanisms of Vascular and Cartilaginous Calcification.血管钙化与软骨钙化的汇聚机制
Biology (Basel). 2024 Jul 26;13(8):565. doi: 10.3390/biology13080565.
6
Vitamin K: a potential missing link in critical illness-a scoping review.维生素 K:危重病中的潜在缺失环节——范围综述。
Crit Care. 2024 Jul 1;28(1):212. doi: 10.1186/s13054-024-05001-2.
7
Vascular Calcification: Molecular Networking, Pathological Implications and Translational Opportunities.血管钙化:分子网络、病理意义及转化机会。
Biomolecules. 2024 Feb 25;14(3):275. doi: 10.3390/biom14030275.
8
New Cardiovascular Biomarkers in Breast Cancer Patients Undergoing Doxorubicin-Based Chemotherapy.接受多柔比星为基础的化疗的乳腺癌患者中的新心血管生物标志物。
Arq Bras Cardiol. 2023 Dec;120(12):e20230167. doi: 10.36660/abc.20230167.
9
Mechanism Analysis of Vascular Calcification Based on Fluid Dynamics.基于流体动力学的血管钙化机制分析
Diagnostics (Basel). 2023 Aug 9;13(16):2632. doi: 10.3390/diagnostics13162632.
10
Updates in the chronic kidney disease-mineral bone disorder show the role of osteocytic proteins, a potential mechanism of the bone-Vascular paradox, a therapeutic target, and a biomarker.慢性肾脏病-矿物质与骨异常的进展显示了骨细胞蛋白的作用、骨-血管矛盾的潜在机制、一个治疗靶点及一种生物标志物。
Front Physiol. 2023 Jan 26;14:1120308. doi: 10.3389/fphys.2023.1120308. eCollection 2023.